NCT02555878 2019-09-12A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer ParticipantsJanssen Research & Development, LLCPhase 3 Completed841 enrolled 24 charts
NCT03214172 2018-09-06Characterizing Recurrent Thromboembolism, Major Bleeding and All-Cause Death in Patients With Cancer-Associated Thromboembolism Treated With RivaroxabanBayerCompleted1,000 enrolled